Depressant and convulsant barbiturates both inhibit neuronal nicotinic acetylcholine receptors

Anesthesia and Analgesia

Volumn 88, Issue 6, 1999, Pages 1406-1411

  Watanabe, Itaru ^a   Andoh, Tomio ^a   Furuya, Ryosuke ^a   Sasaki, Toshio ^a   Kamiya, Yoshinori ^a   Itoh, Hideki ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 5 PHENYL 5 PROPYLBARBITURIC ACID; 5 (2 CYCLOHEXILIDENE ETHYL) 5 ETHYLBARBITURIC ACID; BARBITURIC ACID DERIVATIVE; NICOTINE; NICOTINIC RECEPTOR; THIOPENTAL; UNCLASSIFIED DRUG;

ANESTHESIA MECHANISM; ANIMAL CELL; ARTICLE; CHOLINERGIC RECEPTOR BLOCKING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION;

EID: 0033057743     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199906000-00038     Document Type: Article

References (30)

1. Sargent PB. The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 1993;16:403-43.
2. McGehee DS, Role LW. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 1995;57:521-46.
3. Charlesworth P, Richards CD. Anaesthetic modulation of nicotinic ion channel kinetics in bovine chromaffin cells. Br J Pharmacol 1995;114:909-17.
4. Violet JM, Downie DL, Nakisa RC, et al. Differential sensitivities of mammalian neuronal and muscle nicotinic acetylcholine receptors to general anesthetics. Anesthesiology 1997;86:866-74.
5. Mckenzie D, Franks NP, Lieb WR. Actions of general anaesthetics on a neuronal nicotinic acetylcholine receptor in isolated identified neurones of Lymnaea stagnalis. Br J Pharmacol 1995; 115:275-82.
6. Flood P, Ramirez-Lattorre J, Role L. α4β2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but α7-type nicotinic acetylcholine receptors are unaffected. Anesthesiology 1997;86:859-65.
7. Andoh T, Furuya R, Oka K, et al. Differential effects of thiopental on neuronal nicotinic acetylcholine receptors and P2x purinergic receptors in PC12 cells. Anesthesiology 1997;87:1199-209.
8. Judge SE, Norman J. The action of general anaesthetics on acetylcholine-induced inhibition in the central nervous system of Helix. Br J Pharmacol 1982;75:353-7.
9. Andrews PR, Mark LC. Structural specificity of barbiturates and related drugs. Anesthesiology 1982;57:314-20.
10. Buch HP, Schneider Affeld F, Rummel W. Stereochemical dependence of pharmacological activity in a series of optically active N-methylated barbiturates. Naunyn Schmiedebergs Arch Pharmacol 1973;277:191-8.
11. Skerritt JH, Willow M, Johnston GA. Contrasting effects of a convulsant (CHEB) and an anticonvulsant barbiturate (pheno-barbitone) on amino acid release from rat brain slices. Brain Res 1983;258:271-6.
12. Henderson LP, Godvin MJ, Liu C, et al. Nerve growth factor increases nicotinic Ach receptor gene expression and current density in wild-type and protein kinase A-deficient PC12 cells. J Neurosci 1994;14:1153-63.
13. Flood P, Ramirez-Lattorre J, Role L. Sodium thiopental is a partial agonist: it both causes a dose dependent reduction in and gates current from CNS type nAchRs (α4β2) [abstract]. Anesthesiology 1996;85:632.
14. Hamill OP, Marty A, Neher E, et al. Improved patch-clamp techniques for high-resolutional current recording from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100.
15. Murase K, Ryu PD, Randic M. Excitatory and inhibitory amino acids and peptide-induced responses in acutely isolated rat spinal dorsal horn neurons. Neurosci Lett 1989;103:56-63.
16. Valenta DC, Downing JEG, Role LW. Peptide modulation of Ach receptor desensitization controls neurotransmitter release from chicken sympathetic neurons. J Neurophysiol 1993;69: 928-42.
17. Allan AM, Harris RA. Anesthetic and convulsant barbiturates alter gamma-aminobutyric acid-stimulated chloride flux across brain membranes. J Pharmacol Exp Ther 1986;238:763-8.
18. Franks NP, Lieb WR. Stereospecific effects of inhalational general anesthetic optical isomers on nerve ion channels. Science 1991;254:427-30.
19. Tomlin SL, Jenkins A, Lieb WR, Franks NP. Stereoselective effects of etomidate optical isomers on gamma-aminobutyric acid type A receptors and animals [see comments]. Anesthesiology 1998;88:708-17.
20. Clapham DE, Neher E. Substance P reduces acetylcholine-induced currents in isolated bovine chromaffin cells. J Physiol (Lond) 1984;347:255-77.
21. Roth SH, Forman SA, Braswell LM, Miller KW. Actions of pentobarbital enantiomers on nicotinic cholinergic receptors. Mol Pharmacol 1989;36:874-80.
22. Role L, Berg D. Nicotinic receptors in the development and modulation of CNS synapses. Neuron 1996;16:1077-85.
23. Rogers SW, Mandelzys A, Deneris ES, et al. The expression of nicotinic acetylcholine receptors by PC12 cells treated with NGF. J Neurosci 1992;12:4611-23.
24. Zhang ZW, Vijayaraghavan S, Berg DK. Neuronal acetylcholine receptors that bind alpha-bungarotoxin with high affinity function as ligand-gated ion channels. Neuron 1994;12:167-77.
25. Ifune CK, Steinbach JH. Inward rectification of acetylcholine-elicited currents in rat phaeochromocytoma cells. J Physiol (Lond) 1992;457:143-65.
26. Sands SB, Barish ME. Calcium permeability of neuronal nicotinic acetylcholine receptor channels in PC12 cells. Brain Res 1991;560:38-42.
27. Buisson B, Gopalakrishnan M, Arneric SP, et al. Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: a patch-clamp study. J Neurosci 1996;16:7880-91.
28. Lukas RJ. Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma. J Pharmacol Exp Ther 1989;251:175-82.
29. Gopalakrishnan M, Monteggia LM, Anderson DJ, et al. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor. J Pharmacol Exp Ther 1996;276:289-97.
30. Buisson B, Bertrand D. Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor. Mol Pharmacol 1998;53:555-63.